Pangaea Ventures

Pangaea Ventures is a leading venture capital firm specializing in hard tech and impact investments. Focused on leveraging advancements in materials science, chemistry, and biology, Pangaea Ventures invests in startups addressing global challenges like climate change, food security, and human health. Their portfolio includes innovative companies such as CarbonCure, Aspect Biosystems, and NewLeaf Symbiotics, which are pioneering solutions in carbon sequestration, bioprinted tissues, and sustainable agriculture, respectively. With a geographic focus on North America, Pangaea Ventures typically invests in early to growth-stage companies. Their investment strategy centers around creating measurable impact, often leading investment rounds with significant capital. They are particularly interested in startups that can demonstrate clear, scalable solutions to critical environmental and health problems. Pangaea Ventures' team, based in Vancouver, Scottsdale, and Hillsborough, includes experts like General Partner Chris Erickson, who bring extensive experience in science and business. The firm is known for its rigorous due diligence process and close collaboration with portfolio companies to maximize both financial and impact returns. Startups are encouraged to approach Pangaea with detailed proposals that highlight innovative, market-ready technologies. In summary, Pangaea Ventures is a key player in the venture capital landscape, driving sustainable innovation through strategic investments in transformative technologies.